Hemoglobin Glycation Index and Mortality in NSTEMI Patients Undergoing PCI

A single-center cohort study of 635 patients with non-ST-segment elevation myocardial infarction (NSTEMI) who underwent percutaneous coronary intervention (PCI). The data, authored by Haodong Jiang and published on figshare in 2026, tracks all-cause mortality over a median follow-up of 60 months to investigate the prognostic value of the hemoglobin glycation index.

Use Cases

• Modeling all-cause mortality risk based on hemoglobin glycation index levels.
• Performing survival analysis (Kaplan-Meier, Cox regression) on a patient cohort.
• Conducting subgroup analyses to explore differential associations, such as by sex.
• Investigating linear inverse associations using restricted cubic spline analysis.

Strengths

• Includes 635 patient records, providing a substantive cohort size.
• Features a median follow-up period of 60 months, enabling longitudinal analysis.
• Results are reported with specific hazard ratios and confidence intervals (e.g., HR=0.57, 95% CI: 0.40–0.82).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single-center study, which may limit generalizability.

Provenance

Source

figshare

Collection Method

Single-center cohort study.

Time Range

Patients enrolled between January 2016 and July 2023.

Freshness

Last updated 2026-05-25 04:33:04; freshness should be verified.